NCT07209813
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
464 recruiting studies
Liver Neoplasms trial results
NCT07206511
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
NCT07192848
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center Shenzhen, Guangdong, China
NCT07187284
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery Nanjing, Jiangsu, China
Not Yet Recruiting
Liver Diseases: Extracellular Vesicles as Biomarkers
NCT07185360
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Bichat Hospital, Beaujon Hospital, Cochin Hospital and Lariboisière Hospital Paris, France
Not Yet Recruiting
CT Volume Measurement of Hepatocellular Carcinoma
NCT07183566
- Conditions
- Adenocarcinoma, CT, Carcinoma, +10 more
- Locations
-
Not specified
Not Yet Recruiting
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
NCT07180459
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- People's Hospital of Kaiyang County Guiyang, Guizhou, China
- The Second Affiliated Hospital of Hainan Medical Universsity Haikou, Hainan, China
- Huai He Hospital of Henan University Kaifeng, Henan, China
- Luo He Central Hospital Luohe, Henan, China
NCT07160361
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
NCT07157306
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
NCT07156617
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The Second Affiliated Hospital of Hainan Medical Universsity Haikou, Hainan, China
- Xingtai No.5 Hospital Xingtai, Hebei, China
- Deng zhou People's Hospital Dengzhou, Henan, China
- The Second People's Hospital of Jiaozuo Jiaozuo, Henan, China